Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Men generally have higher blood pressure than premenopausal women, but postmenopausal women's blood pressure can surpass men's, and hormone therapy doesn't significantly help.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Early onset hair loss linked to genetics and androgen levels.

DHT stops hair regrowth in mice, similar to human hair loss.

PRP treatment improves hair count, density, and reduces hair loss in AGA patients.

Finasteride use changes brain chemicals, causing lasting sexual issues and anxiety/depression.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

PRGF treatment safely and effectively helps hair loss.

Iron and zinc deficiencies may be treated to help female hair loss.

Sebocytes play a key role in controlling androgen levels in human skin.

Hair loss in men is common, treatable, but not curable.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Lower zinc levels may predict less effective hair loss treatment.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Genetics and hormones cause hair loss; finasteride treats it safely.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

PRP treatment may stimulate hair growth by promoting blood vessel formation, increasing growth factors, and preventing cell death.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Hidradenitis suppurativa improves with antiandrogen therapy.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

PRP therapy safely improves hair growth in people with hair loss.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.